Search This Blog

Tuesday, January 15, 2019

Argenx granted orphan status for acute myeloid leukemia treatment


The FDA granted Argenx orphan status for cusatuzumab, its treatment of acute myeloid leukemia, according to a post on the agency’s website.
Posted by at

No comments:

Post a Comment

Note: Only a member of this blog may post a comment.

Subscribe to: Post Comments (Atom)